Body mass index in patients with Parkinson's disease: a meta-analysis

Yinghui Li,Yumei Liu,Chuanning Du,Jun Wang
DOI: https://doi.org/10.1152/jn.00363.2023
2024-01-26
Journal of Neurophysiology
Abstract:Body mass index (BMI) has been found to have an impact on neurodegenerative diseases such as Parkinson's disease (PD). Several studies suggested that PD patients have a lower BMI compared to controls. However, some studies indicated the differences between patients and controls as statistically insignificant. We performed this meta-analysis to clarify the relationship between BMI and PD on basis of the studies published from 1975 to Apr 2023 in the PubMed, EMBASE, and Cochrane Library databases. In total, 18 case-control studies met the inclusion criteria for meta-analysis. We found a statistically significant difference of mean BMI between PD patients and healthy controls [standardized mean difference (SMD) (95% confidence interval (CI): −0.36 (−0.43, −0.29), p < 0.05]. Regarding sex, 7 studies were included in the meta-analysis for female/male PD patients. The mean BMI was significantly different between males with PD and healthy males [SMD (95% CI): −0.34 (−0.47, −0.22), p < 0.05]. Moreover, the mean BMI of females with PD was significantly different from that of corresponding healthy females [SMD (95% CI): −0.44 (−0.57, −0.30), p < 0.05]. The meta-analysis demonstrates a significant lower BMI in patients with PD, but no gender differences, when compared to their respective healthy individuals.
neurosciences,physiology
What problem does this paper attempt to address?